Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Amortization - Intangibles came in at $138.0 million in Q1 2026, up 7.81% year-on-year from $128.0 million in Q1 2025, and down 0.72% quarter-over-quarter from $139.0 million in Q4 2025.
Elanco Animal Health (ELAN) Amortization - Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Amortization - Intangibles across 10 years of filings, most recently posting $138.0 million for Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $138.0 million, up 7.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $553.0 million (up 5.94% YoY), and the FY2025 annual result was $543.0 million, up 3.04% from the prior year.
- Amortization - Intangibles came in at $138.0 million for Q1 2026 at Elanco Animal Health, down from $139.0 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $140.0 million in Q3 2023 to a low of $128.0 million in Q3 2022.
- The 5-year median for Amortization - Intangibles is $134.0 million (2023), against an average of $134.4 million.
- Across the five-year window, Amortization - Intangibles dropped 9.22% in 2022 and increased 9.38% in 2023, its largest moves.
- Elanco Animal Health's Amortization - Intangibles stood at $130.0 million in 2022, then grew by 6.15% to $138.0 million in 2023, then dropped by 5.8% to $130.0 million in 2024, then advanced by 6.92% to $139.0 million in 2025, then declined by 0.72% to $138.0 million in 2026.
- The last three Amortization - Intangibles figures came in at $138.0 million (Q1 2026), $139.0 million (Q4 2025), and $140.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.00 Mn |
| Dec 31, 2025 | 139.00 Mn |
| Sep 30, 2025 | 140.00 Mn |
| Jun 30, 2025 | 136.00 Mn |
| Mar 31, 2025 | 128.00 Mn |
| Dec 31, 2024 | 130.00 Mn |
| Sep 30, 2024 | 133.00 Mn |
| Jun 30, 2024 | 131.00 Mn |
| Mar 31, 2024 | 133.00 Mn |
| Dec 31, 2023 | 138.00 Mn |
| Sep 30, 2023 | 140.00 Mn |
| Jun 30, 2023 | 136.00 Mn |
| Mar 31, 2023 | 134.00 Mn |
| Dec 31, 2022 | 130.00 Mn |
| Sep 30, 2022 | 128.00 Mn |
| Jun 30, 2022 | 133.00 Mn |
| Mar 31, 2022 | 137.00 Mn |
| Dec 31, 2021 | 139.00 Mn |
| Sep 30, 2021 | 141.00 Mn |
| Jun 30, 2021 | 129.00 Mn |